Explore UAB

  • UAB researchers part of GRADE study investigating glucose medications in Type 2 diabetes
    UAB researchers say the presented data indicates that a younger age and higher HbA1c at baseline predict early treatment failure and point to the need for more aggressive initial treatment in these patients.
  • Heart Health 101: UAB expert offers top tips for heart-healthy diet
    A healthy lifestyle is about small changes over time that build upon each other.
  • Fran Lund, Ph.D., named an AAI Distinguished Fellow
    Lund is the fifth Distinguished Fellow from UAB named since 2019, a sign of the strength of immunology research at UAB.
  • UAB resident discovers mysterious fatigue was Type 1 diabetes
    From January to May of 2023, Shelby Lyda, M.D., was extremely tired and had brain fog, but she chalked it up to the demands of a residency program.
  • Type 1 diabetes: B cell-derived natural antibodies suppress autoimmune pathogenesis
    Vaccination of neonatal mice with group A Streptococcus promotes clonal expansion of B cells that produce antibody against GlcNAc. The association of reduced Type 1 diabetes risk after group A Streptococcus infection is dependent on these GlcNAc-specific B cells.
  • UAB employee reflects on receiving Type 1 diabetes diagnosis in rural south
    Department of Medicine Facilities Coordinator Corey Cates, M.S., was six years old when he was diagnosed with Type 1 diabetes. For doctors to uncover Cates’ diagnosis, it took a two-and-a-half-hour drive as well as a one-week stay at the Children's Medical Center in Dallas, TX in 1996.
  • Tackle football season with five diabetes-friendly tailgating tips
    UAB diabetes expert serves up tailgating hacks to make football season fun and diabetes-friendly.
  • In Type 1 diabetes, verapamil prevents decline of IGF-1 and promotes beta-cell IGF-1 signaling
    These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1.
  • March Milestones at UAB
    In March 2023, UAB celebrated the Medical Alumni Association’s 50th Annual Medical Alumni Weekend, the 70th Anniversary of Birmingham Veterans Affairs Medical Center and the 15th Anniversary of UAB Comprehensive Diabetes Center. These milestones serve as an excellent opportunity to look at where we started and a reminder to look forward to all we wish to achieve.
  • UAB to host Endocrinology Update Conference
    The UAB Division of Endocrinology, Diabetes, and Metabolism, alongside the Division of Endocrine Surgery, is pleased to offer the 2023 Endocrinology Update Conference on Saturday, August 19 beginning at 8 a.m. at the Hilton Birmingham at UAB.
  • Ashraf co-edits textbook on pediatric dyslipidemia
    Department of Pediatrics Professor and Ralph Froshin Endowed Chair in Pediatric Endocrinology Ambika Ashraf, M.D., co-edited a book “Pediatric Dyslipidemia” alongside colleague Bhuvana Sunil, M.D.
  • UAB welcomes renowned diabetes researchers Ananda and Rita Basu
    The University of Alabama at Birmingham Heersink School of Medicine and the UAB Comprehensive Diabetes Center (UCDC) are pleased to welcome Ananda Basu, M.D., and Rita Basu, M.D., as full professors into the Division of Endocrinology, Diabetes, and Metabolism.
  • Ramanadham secures two JDFR grants for T1D research
    Over one million Americans are living with Type 1 diabetes (T1D). According to Beyond Type 1, the number of those with T1D is steadily climbing at 2.9% per year, versus the population growth of 0.8% per year.
  • UAB receives $3.7 million to study diabetes in minority youth
    UAB is one of 15 sites selected by the NIH to study the increasing prevalence of diabetes in youth, specifically in Black and Hispanic minority groups.
  • Three UAB studies look at obesity in-utero and how it affects offspring as part of four-center study
    Three teams of researchers from UAB are analyzing the intergenerational transmission of obesity.